In-Silico Structure Database (LMISSD)

Back
Overview
Browse
Search

LMISSD: Sum Composition Results

Abbreviation Formula Mass Main Class Sub Class
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C70H129NO27 1415.875206 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C68H124N2O28 1416.834070 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C68H124N2O28 1416.834070 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C68H124N2O28 1416.834070 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C68H124N2O28 1416.834070 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C68H123N3O28 1429.829318 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C68H123N3O28 1429.829318 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C68H123N3O28 1429.829318 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C68H123N3O28 1429.829318 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C70H129NO28 1431.870121 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C72H131NO27 1441.890856 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C72H133NO27 1443.906506 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C70H128N2O28 1444.865370 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C70H128N2O28 1444.865370 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C70H128N2O28 1444.865370 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C70H128N2O28 1444.865370 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C70H127N3O28 1457.860618 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C70H127N3O28 1457.860618 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C70H127N3O28 1457.860618 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 36:1;O2 C70H127N3O28 1457.860618 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C72H131NO28 1457.885771 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C72H133NO28 1459.901421 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C74H135NO27 1469.922156 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C74H137NO27 1471.937806 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C72H132N2O28 1472.896670 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C72H132N2O28 1472.896670 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C72H132N2O28 1472.896670 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C72H132N2O28 1472.896670 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C72H131N3O28 1485.891919 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C72H131N3O28 1485.891919 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C72H131N3O28 1485.891919 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 38:1;O2 C72H131N3O28 1485.891919 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C74H135NO28 1485.917071 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:1;O2 C74H137NO28 1487.932721 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C74H134N2O28 1498.912320 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C74H134N2O28 1498.912320 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C74H134N2O28 1498.912320 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 42:2;O2 C74H134N2O28 1498.912320 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C74H136N2O28 1500.927970 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C74H136N2O28 1500.927970 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C74H136N2O28 1500.927970 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer 42:1;O2 C74H136N2O28 1500.927970 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 34:1;O2 C70H127NO33 1509.829046 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcα1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C74H135N3O28 1513.923219 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3(GalNAcβ1-4)Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C74H135N3O28 1513.923219 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C74H135N3O28 1513.923219 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-6GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 40:1;O2 C74H135N3O28 1513.923219 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C76H138N2O28 1526.943620 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C76H138N2O28 1526.943620 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer 44:2;O2 C76H138N2O28 1526.943620 Neutral glycosphingolipids [SP05] Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]